APAC Contract Pharmaceutical Packaging Market - Industry Trends and Forecast to 2030
Asia-Pacific contract pharmaceutical packaging market is expected to reach USD 2,688,413.62 Thousand by 2030 from USD 1,501,794.32 Thousand in 2022, growing at a CAGR of 7.7% in the forecast period of 2023 to 2030
Market Segmentation: Asia-Pacific Contract Pharmaceutical Packaging Market, By Type (Primary Packaging System, Secondary Packaging System, and Tertiary Packaging System), Raw Material (Plastic & Polymers, Glass, Metals, Paper & Board, Rubber, Cotton, and Others), Application (Transmucosal Drug Delivery Packaging, Pulmonary Drug Delivery Packaging, Nasal Drug Delivery Packaging, Topical Drug Delivery Packaging, Injectable Packaging, Oral Drug Delivery Packaging, and Others), Country (China, India, Japan, South Korea, Australia and New Zealand, Indonesia, Singapore, Malaysia, Thailand, Philippines, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2030
Overview of Asia-Pacific Contract Pharmaceutical Packaging Market Dynamics
Driver • Impact of regulatory compliance and quality assurance demands Restraint • Sustainability concerns due to usage of plastics in packaging materials
Opportunity
• Rising need for biopharmaceutical cold chain packaging
Market Players:
Some of the key market players operating in the Asia-Pacific contract pharmaceutical packaging market are: • AbbVie Inc • PCI Pharma Services • Nelipak Healthcare • Sharp Services, LLC • Aphena Pharma Solutions • ROPACK INC. • SilganUnicep • Reed-Lane, • Jones Healthcare Group • Wasdell Packaging Group • SternMaid &Co. KG • Sepha • Tripak Pharmaceuticals • Assemblies Unlimited, Inc. • AmeriPac • Tjoapack
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modeling
2.7 Primary Interviews With Key Opinion Leaders
2.8 Dbmr Market Position Grid
2.9 Market Application Coverage Grid
2.10 Dbmr Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestle Analysis
4.1.1 Political Factors:
4.1.2 Economic Factors:
4.1.3 Social Factors:
4.1.4 Technological Factors:
4.1.5 Legal Factors:
4.1.6 Environmental Factors:
4.2 Porter’s Five Forces
4.3 Vendor Selection Criteria 38
5 Dynamics Of Raw Material Preferences
5.1 Plastic And Polymers:
5.1.1 Hdpe (High-density Polyethylene):
5.1.2 Ldpe (Low-density Polyethylene):
5.1.3 Pet (Polyethylene Terephthalate):
5.1.4 Pvc (Polyvinyl Chloride):
5.1.5 Pp (Polypropylene):
5.1.6 Coc (Cyclic Olefin Copolymer):
5.2 Glass:
5.2.1 Type Iv-np (General Purpose Soda Lime Glass):
5.2.2 Type I (Borosilicate Glass):
5.2.3 Type Iii (Regular Soda-lime Glass):
5.2.4 Treated Soda Lime Glass:
5.3 Metal:
5.3.1 Tin:
5.3.2 Iron:
5.3.3 Aluminium:
5.3.4 Lead:
5.4 Paper And Board:
5.4.1 Solid Board:
5.4.2 Chipboard:
5.4.3 Cardboard:
5.4.4 Fiber Board:
5.5 Rubber:
5.5.1 Natural Rubber In Contract Pharmaceutical Packaging:
5.5.2 Neoprene Rubber In Contract Pharmaceutical Packaging:
5.5.3 Butyl Rubber In Contract Pharmaceutical Packaging:
6 Partnership Details
7 Technological Advancements
8 Market Overview
8.1 Drivers
8.1.1 Strong Spending Towards Pharma Industry
8.1.2 Impact Of Complex Drug Formulations And Specialized Packaging Needs
8.1.3 Impact Of Regulatory Compliance And Quality Assurance Demands
8.2 Restraints
8.2.1 Availability Of Choice Of In-house Packaging From Manufacturers
8.2.2 Sustainability Concerns Due To Usage Of Plastics In Packaging Materials 54
8.3 Opportunities
8.3.1 Technological Advancements In Packaging Machinery And Materials
8.3.2 Rising Need For Biopharmaceutical Cold Chain Packaging
8.4 Challenge
8.4.1 Diverse Concerns Related To Operational Hurdles
9 Asia-pacific Contract Pharmaceutical Packaging Market: By Region
9.1 Asia-pacific
10 Asia-pacific Contract Pharmaceutical Packaging Market: Company Landscape
Figure 12 Strong Spending Towards Pharma Industry Is Expected To Drive The Growth Of The Asia-pacific Contract Pharmaceutical Packaging Market In The Forecast Period
Figure 13 The Primary Packaging System Segment Is Expected To Account For The Largest Market Share Of The Asia-pacific Contract Pharmaceutical Packaging Market In 2023 And 2030
Figure 14 Vendor Selection Criteria
Figure 15 Drivers, Restraints, Opportunities, And Challenges Of The Asia-pacific Contract Pharmaceutical Packaging Market
Figure 16 Fdi Inflows In Drugs & Pharmaceuticals Activities